ArticleJournal of experimental & clinical cancer research : CR2024

Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer.

Yao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.